Is It Too Late to Buy SpaceX?

SpaceX completed a record IPO, raising $75 billion initially and $85.7 billion after the overallotment option, with the stock briefly up 40% from its opening price and a valuation above $2.5 trillion. The article highlights strong investor enthusiasm but also warns that Morningstar’s fair value estimate of $62 implies substantial overvaluation and that heavy AI-related capex drove a $4.9 billion net loss. The stance is cautiously constructive on the long-term story, but near-term risk and valuation are emphasized.

Analysis

The real market signal here is not “SpaceX is expensive,” but that private-market capital formation is now competing directly with public growth tech for liquidity and narrative attention. A trillion-plus valuation for a still-capex-heavy, pre-mature profitability story can siphon incremental risk budget away from adjacent high-beta tech leaders, while also forcing benchmarked growth managers to decide whether they want exposure to a far less liquid, much more execution-dependent asset.

Second-order, the biggest near-term beneficiary is not SpaceX itself but the ecosystem around it: launch suppliers, high-reliability components, ground-network vendors, and any public software/AI names that can be framed as picks-and-shovels to orbital connectivity. The biggest loser is valuation discipline across unprofitable growth—this kind of print can re-rate the whole cohort for a few weeks, but it also raises the bar for future IPOs because investors will demand a credible path from capital intensity to unit economics, not just a compelling founder story.

The key risk is timing mismatch. The article’s setup assumes long-dated optionality can be underwritten at near-term public-market prices, but the more likely path is intermittent drawdowns as each earnings/capex disclosure forces a reset of what “massive growth phase” actually costs. If revenue growth slows even modestly over the next 2-3 quarters, multiple compression can happen faster than fundamental progress, especially if retail demand exhausts itself after the initial listing momentum.

Contrarian view: the market may be overpricing the strategic moat while underpricing financing risk. If the business truly requires sustained double-digit billions of capex for years, equity holders are effectively funding a space infrastructure buildout at a premium multiple; that can work only if dilution or execution doesn’t surprise negatively. In contrast, the more durable trade may be in established public AI and connectivity leaders that benefit from the halo effect without needing to prove a Mars-scale endgame.

Key Decisions for Investors

• Fade the enthusiasm with a small short via put spreads on the newly listed name over the next 1-3 months; target a reversion toward the first post-IPO support zone if capex commentary stays heavy.
• Long NVDA/MSFT on any broad growth selloff caused by capital rotation into SpaceX-style narratives; both should benefit if investors re-anchor on cash-flow-rich AI platforms rather than pre-profitability moonshots.
• Consider a relative-value pair: long large-cap AI infrastructure providers, short the most expensive pre-profitability space/connectivity proxy basket, for a 3-6 month horizon; the spread should work if the market starts pricing execution risk more rationally.
• Watch MORN as a sentiment tell: if retail enthusiasm drives more “buy the dip” behavior in speculative listings, expect research/content platforms to see temporary engagement tailwinds, but treat it as a trading signal rather than a durable fundamental thesis.